Posts by Heather Hare

Career Opportunity: Clinical Fellowship in Huntington Disease Research at UBC

Career Opportunity: Clinical Fellowship in Huntington Disease Research at UBC

A funded Clinical Research Fellowship is available for a medical graduate with an interest in neurology, medical genetics, or psychiatry...

HSG Leadership Election Results

On behalf of the HSG Nominating Committee, it is with great pleasure that we announce that Andrew Feigin and Elise...

2018 HSG Election

Dear HSG Members, Below is the content of an email that all HSG members should have received today. If you...

Ionis and Roche announce promising news on the Ionis-HTTRx trial

Ionis and Roche announced Monday, Dec. 11, that the Phase 1/2a Ionis-HTTRx trial reported no significant safety issues among participants....

Loss of our friend, Dr. Kimberly Quaid de Cordon

We heard today that Kimberly Quaid de Cordon, PhD, died in a tragic accident, and we now are mourning the loss...

Welcome new staff member, members of leadership team

The Huntington Study Group is pleased to announce a new staff member and new members of the leadership team. Anne...

Overnight Switch from Tetrabenazine to Deutetrabenazine Safe, Trial Shows

JAMA Neurology paper published today from ARC-HD Trial People with Huntington disease-associated chorea can safely convert overnight from tetrabenazine to...

HD Insights Volume 17 (PDF)

For a non-PDF version of HD Insights Vol. 17, click here.

FDA approves deutetrabenazine (AUSTEDO™) to treat chorea

On April 3, 2017, the FDA approved a new drug, deutetrabenazine, to treat HD-associated chorea. By: Sara LaJeunesse, MSc Deutetrabenazine...

Meet the Scientist : Beverly Davidson

VITAL SIGNS NAME: Beverly Davidson, PhD TITLE: Chief Scientific Strategy Officer at the Children’s Hospital of Philadelphia (CHOP); Director of...

1 2 3 14